Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14572748rdf:typepubmed:Citationlld:pubmed
pubmed-article:14572748lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C0239307lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C0035168lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C0038467lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C0751569lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C0205276lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C0596019lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C0029237lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C0282461lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C0458083lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C1521738lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C0870509lld:lifeskim
pubmed-article:14572748lifeskim:mentionsumls-concept:C1285530lld:lifeskim
pubmed-article:14572748pubmed:issue5lld:pubmed
pubmed-article:14572748pubmed:dateCreated2003-10-23lld:pubmed
pubmed-article:14572748pubmed:abstractTextTo compare toxicity, subjective response rate, time to subjective progression and overall survival in patients with painful bone metastases of hormone-resistant prostate cancer (HRPC) treated with a single intravenous injection of 150MBq (4mCi) Strontium(89) Chloride (S) or palliative local field radiotherapy (R) with the usual radiotherapy regimen used at each centre. The costs of both treatments were also assessed.lld:pubmed
pubmed-article:14572748pubmed:languageenglld:pubmed
pubmed-article:14572748pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14572748pubmed:citationSubsetIMlld:pubmed
pubmed-article:14572748pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14572748pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14572748pubmed:statusMEDLINElld:pubmed
pubmed-article:14572748pubmed:monthNovlld:pubmed
pubmed-article:14572748pubmed:issn0302-2838lld:pubmed
pubmed-article:14572748pubmed:authorpubmed-author:RobertsJ TJTlld:pubmed
pubmed-article:14572748pubmed:authorpubmed-author:EngelholmS...lld:pubmed
pubmed-article:14572748pubmed:authorpubmed-author:von der...lld:pubmed
pubmed-article:14572748pubmed:authorpubmed-author:HorenblasSSlld:pubmed
pubmed-article:14572748pubmed:authorpubmed-author:CollettiPPlld:pubmed
pubmed-article:14572748pubmed:authorpubmed-author:NeymarkNNlld:pubmed
pubmed-article:14572748pubmed:authorpubmed-author:DeboisMMlld:pubmed
pubmed-article:14572748pubmed:authorpubmed-author:de ReijkeTh...lld:pubmed
pubmed-article:14572748pubmed:authorpubmed-author:OosterhofG...lld:pubmed
pubmed-article:14572748pubmed:issnTypePrintlld:pubmed
pubmed-article:14572748pubmed:volume44lld:pubmed
pubmed-article:14572748pubmed:ownerNLMlld:pubmed
pubmed-article:14572748pubmed:authorsCompleteYlld:pubmed
pubmed-article:14572748pubmed:pagination519-26lld:pubmed
pubmed-article:14572748pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:meshHeadingpubmed-meshheading:14572748...lld:pubmed
pubmed-article:14572748pubmed:year2003lld:pubmed
pubmed-article:14572748pubmed:articleTitleStrontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group.lld:pubmed
pubmed-article:14572748pubmed:affiliationDepartment of Urology, Academic Hospital, Nijmegen, The Netherlands. g.oosterhof@urology.azm.nllld:pubmed
pubmed-article:14572748pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14572748pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:14572748pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:14572748pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:14572748pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14572748lld:pubmed